Galectin Therapeutics Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar '26 Mar 31, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Cash & Equivalents	14.11	17.72	15.12	25.66	18.59	39.65
Cash & Short-Term Investments	14.11	17.72	15.12	25.66	18.59	39.65
Cash Growth	89.89%	17.20%	-41.08%	38.02%	-53.11%	46.08%
Other Current Assets	1.58	1.72	2.13	2.05	1.96	2.17
Total Current Assets	15.69	19.44	17.25	27.71	20.55	41.82
Net Property, Plant & Equipment	0.07	0.1	0.24	0.49	0.73	0.01
Total Assets	15.76	19.53	17.5	28.2	21.29	41.83
Accounts Payable	3.12	3.25	5.66	6.43	3.89	1.81
Accrued Expenses	4.19	4.72	8.2	9.18	9.06	7.16
Current Portion of Long-Term Debt	-	-	21.12	-	-	-
Other Current Liabilities	-	0.06	0.43	0.06	0.06	0.07
Total Current Liabilities	7.31	8.03	35.41	15.68	13.01	9.03
Long-Term Debt	135.71	133.74	85.11	71.74	39.83	29.05
Other Long-Term Liabilities	2.98	3.96	0.05	1.02	0.64	1.13
Total Long-Term Liabilities	138.69	137.7	85.16	72.77	40.47	30.18
Total Liabilities	146	145.73	120.57	88.44	53.48	39.21
Preferred Stock	0.48	0.49	0.5	0.5	0.51	0.53
Common Stock	0.07	0.07	0.06	0.06	0.06	0.06
Additional Paid-in Capital	305.11	304.07	296.22	291.85	275.08	271
Retained Earnings	-437.61	-432.55	-401.57	-354.37	-309.57	-270.69
Total Common Shareholders' Equity	-131.96	-127.92	-104.79	-61.96	-33.92	0.89
Minority Interest	1.72	1.72	1.72	1.72	1.72	1.72
Shareholders' Equity	-130.24	-126.2	-103.07	-60.24	-32.19	2.62
Total Liabilities & Equity	15.76	19.53	17.5	28.2	21.29	41.83
Total Debt	135.71	133.74	106.23	71.74	39.83	29.05
Net Cash (Debt)	-121.6	-116.02	-91.11	-46.08	-21.24	10.6
Net Cash Growth	-	-	-	-	-	-60.95%
Net Cash Per Share	-1.86	-1.81	-1.46	-0.77	-0.36	0.18
Book Value	-131.96	-127.92	-104.79	-61.96	-33.92	0.89
Book Value Per Share	-2.02	-2.00	-1.68	-1.03	-0.57	0.02
Tangible Book Value	-131.96	-127.92	-104.79	-61.96	-33.92	0.89
Tangible Book Value Per Share	-2.02	-2.00	-1.68	-1.03	-0.57	0.02

Updated May 15, 2026. Data Source: Fiscal.ai. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q